[257 Pages Report] The global top 10 bioprocess technology market is expected to USD 71.03 Billion by 2021 from USD 39.30 Billion in 2016, at a CAGR of 12.4% between 2016 and 2021.

Growth in the biopharmaceutical industry, increase in R&D spending, rising demand for vaccine production, and technological advancements form important growth drivers for this market. On the other hand, stringent regulatory policies and high cost of instruments are restraining market growth for bioprocess technologies.

The report provides an overall understanding of the global top 10 bioprocess technology market. This report segments the market on the basis of type and region.

On the basis of type, the market is segmented into cell culture, cell expansion, cell counting, cell line development, flow cytometry, single-use bioprocessing, biologics safety testing, virus filtration, tangential flow filtration, and pyrogen testing. In 2016, the cell culture segment is expected to account for the largest share of the global top 10 bioprocess technology market.

On the basis of region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The report maps each bioprocess technology in these geographic and regional segments.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global top 10 bioprocess technology market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

In 2016, North America accounted for the largest share of the global top 10 bioprocess technology market. Growth in this market can be attributed to the increase in demand of high quality biologics, rising spending on R&D by top players in this region. Similarly, Asia is estimated to grow at the highest CAGR during the forecast period. The growth of this market is fueled by overall growth in the biopharmaceutical industry, investments by key market players in Asia countries, increasing government support, developments in R&D infrastructure, increasing outsourcing to Asia countries, and growing expertise and academic excellence in Asia.

The prominent players in the top 10 bioprocess technology market include GE Healthcare (U.S.), Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France), Corning, Inc.(U.S.), Bio-Rad Laboratories (U.S.), and Charles River Laboratories (U.S.).

Target audience for this report:

Academic Research Institutes

Pharmaceutical Companies

Biotechnology Companies

Bioprocess Technology Manufacturing Companies

Contract Research Organizations (CROs)

Market Research & Consulting Firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the global top 10 bioprocess technology market into the following segments and subsegments:

Global top 10 bioprocess technology Market, by Type

Cell culture Equipment Cell culture supporting equipment Cell culture storage equipment Cell culture vessels Bioreactors CONSUMABLES Sera Media Reagents Bioreactor accessories

Cell expansion CONSUMABLES Reagents, media, and serum Disposables INSTRUMENTS Cell expansion supporting equipment Bioreactors Automated cell expansion systems

Cell counting CONSUMABLES AND ACCESSORIES Reagents Assay kits Microplates Accessories Others INSTRUMENTS Spectrophotometers Flow cytometers Hematology analyzers Cell counters

Cell line development EQUIPMENT Biosafety cabinets Cell counters & viability analysis systems Incubators Centrifuges Bioreactors Storage equipment Automation systems Microscopes Filtration systems Other cell line development equipment MEDIA & REAGENTS Sera Media Reagents

Flow Cytometry Reagents and consumables Instruments Accessories

Single-use Bioprocessing Media bags and containers Filtration assemblies Disposable/single-use bioreactors Disposable mixers Other products (tubing, connectors, and samplers)

Biologics Safety Testing Kits & reagents Instruments

Virus Filtration Kits and reagents Filtration systems Other products

Tangential Flow Filtration Single-use systems Reusable systems Membrane filters Filtration accessories

Pyrogen Testing Kits and reagents Instruments



Global top 10 bioprocess technology Market, by Region

North America U.S. Canada

Europe

Asia

Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Geographic Analysis

Further breakdown of the top 10 bioprocess technology market into specific countries/regions in Asia, Europe, and Rest of The World

Company Information

Detailed analysis and profiling of additional market players (Up to 5)

The top 10 bioprocess technology market is expected to USD 71.03 Billion by 2021 from USD 39.30 Billion in 2016, at a CAGR of 12.4% between 2016 and 2021. Growth in the biopharmaceutical industry, increase in R&D spending, rising demand for vaccine production, and technological advancements form important growth drivers for this market during the forecast period. The rising opportunities in emerging market and increasing pharmaceutical outsourcing provide significant growth opportunities for players operating in the top 10 bioprocess technology market.

The report provides an overall understanding of the global top 10 bioprocess technology market. It segments the global market on the basis of type and region. On the basis of type, the market is segmented into cell culture, cell expansion, cell counting, cell line development, flow cytometry, single-use bioprocessing, biologics safety testing, virus filtration, tangential flow filtration, and pyrogen testing. In 2016, the cell culture segment is expected to account for the largest share of the global top 10 bioprocess technology market. The largest share of this segment is primarily attributed to the repeated purchase of consumables as compared to equipment and increase in funding for cell-based research.

On the basis of region, the market is segmented into North America, Europe, Asia, and RoW. The report maps each bioprocess technology in these geographic and regional segments. In 2016, North America is expected to account for the largest share of the global top 10 bioprocess technology market. Growth in this market can be attributed to the increase in demand of high quality biologics and rising spending on R&D by top players in this region. Similarly, Asia is estimated to grow at the highest CAGR during the forecast period. The wide applications of bioprocess technology in the biopharmaceutical and pharmaceutical industry are expected to drive the demand for top 10 bioprocess technology market in this region.

The major players in top 10 bioprocess technology market include GE Healthcare (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Lonza Group AG (Switzerland), Merck Millipore (Germany), Sartorius Stedim Biotech S.A (France), Corning, Inc. (U.S.), Bio-Rad Laboratories (U.S.), and Charles River Laboratories (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst